Skip to main content
. 2024 Jun 17;33(8):2219–2233. doi: 10.1007/s11136-024-03689-x

Table 1.

Characteristics of the non-long stayers (n = 222), long stayers (n = 63) and total population (N = 285)

Full population Non-long stayers Long stayers
Intervention group (N = 148) Control group (N = 137) Total (N = 285) Intervention group (N = 106) Control group (N = 116) Total (N = 222) Intervention group (N = 42) Control group (N = 21) Total (N = 63)
Age, years
 Mean (SD) 82.8 (6.0) 82.1 (5.9) 82.5 (6.0) 82.4 (6.1) 81.9 (5.9) 82.2 (6.0) 83.9 (5.9) 82.9 (6.1) 83.5 (5.9)
 70–74 years, n (%)a 16 (10.8) 21 (15.3) 37 (13.0) 12 (11.3) 19 (16.4) 31 (14.0) 4 (9.5) 2 (9.5) 6 (9.5)
 75–79 years, n (%)a 27 (18.2) 24 (17.5) 51 (17.9) 20 (18.9) 19 (16.4) 39 (17.6) 7 (16.7) 5 (23.8) 12 (19.1)
 80–84 years, n (%)a 44 (29.7) 42 (30.7) 86 (30.2) 32 (30.2) 39 (33.6) 71 (32.0) 12 (28.6) 3 (14.3) 15 (23.8)
  ≥ 85 years, n (%)a 61 (41.2) 50 (36.5) 111 (39.0) 42 (39.6) 39 (33.6) 81 (36.5) 19 (45.2) 11 (52.4) 30 (47.6)
Sex, n (%)
 Female 74 (54.0) 98 (66.2) 172 (60.4) 69 (65.1) 65 (56.0) 134 (60.4) 29 (69.1) 9 (42.9) 38 (60.3)
Level of education, n (%)
 Low (< 12 years) 75 (52.8) 73 (54.1) 148 (53.4) 52 (49.1) 64 (55.2) 116 (52.3) 23 (54.8) 9 (42.9) 32 (50.8)
 High (> 12 years) 67 (47.2) 62 (45.9) 129 (46.6) 50 (47.2) 50 (43.1) 100 (45.1) 17 (40.5) 12 (57.1) 29 (46.0)
 Missing 6 (4.1) 2 (1.5) 8 (2.8) 4 (3.8) 2 (1.7) 6 (2.7) 2 (4.8) 0 (0.0) 2 (3.2)
Living status, n (%)
 Home-dwelling before included 137 (92.6) 129 (94.2) 266 (93.3) 100 (94.3) 111 (95.7) 211 (95.1) 37 (88.1) 18 (85.7) 55 (87.3)
 Living alone before included 86 (58.5) 82 (59.9) 168 (59.2) 59 (56.2) 69 (59.5) 128 (57.9) 27 (64.3) 13 (61.9) 40 (63.5)
 Discharged home 113 (76.4) 101 (74.3) 214 (75.4) 91 (85.9) 91 (78.5) 182 (82.0) 22 (52.4) 10 (50.0) 32 (51.6)
Need for assistance, n (%)
 Home-care services 75 (50.7) 77 (56.2) 152 (53.3) 48 (45.3) 63 (54.3) 111 (50.0) 27 (64.3) 14 (66.7) 41 (65.1)
 Multidose adherence aid 43 (29.0) 48 (35.0) 91 (31.9) 28 (25.5) 38 (32.8) 65 (29.3) 16 (38.1) 10 (47.6) 26 (41.3)
 Handling own medications 77 (52.0) 64 (46.7) 141 (49.5) 59 (55.7) 58 (50.0) 117 (52.7) 18 (42.9) 6 (28.6) 24 (38.1)
Medication use, admission, mean (SD)
 Number of medications regular use 6.6 (4.0) 7.4 (4.0) 7.0 (4.0) 6.8 (4.1) 7.2 (4.0) 7.0 (4.0) 6.4 (3.9) 8.5 (3.9) 7.1 (4.0)
 Number of medications total 8.7 (5.1) 9.6 (5.4) 9.1 (5.2) 8.8 (5.1) 9.4 (5.4) 9.1 (5.3) 8.5 (5.1) 10.5 (5.1) 9.1 (5.2)
 Medications total < 5, n (%)a 31 (21.0) 23 (16.8) 54 (19.0) 20 (18.9) 22 (19.0) 42 (18.9) 11 (26.2) 1 (4.8) 12 (19.1)
 Medications total ≥ 5, n (%)a 117 (79.1) 114 (83.2) 231 (81.1) 86 (81.1) 94 (81.0) 180 (81.1) 31 (73.8) 20 (95.2) 51 (81.0)
Medication use, discharge, mean (SD)
 Number of medications regular use 7.0 (3.6) 7.6 (3.8) 7.3 (3.7) 6.9 (3.5) 7.5 (3.9) 7.2 (3.7) 7.3 (3.8) 8.1 (3.4) 7.6 (3.6)
 Number of medications total 10.3 (5.0) 10.4 (5.5) 10.3 (5.2) 10.2 (5.0) 10.3 (5.6) 10.2 (5.3) 10.8 (5.0) 10.7 (4.5) 10.7 (4.8)
 Medications total < 5, n (%)a 16 (10.8) 16 (11.7) 32 (11.2) 12 (11.3) 15 (12.9) 27 (12.2) 4 (9.5) 1 (4.8) 5 (7.9)
 Medications total ≥ 5, n (%)a 132 (89.2) 121 (88.3) 253 (88.8) 94 (88.7) 101 (87.1) 195 (87.8) 38 (90.5) 20 (95.2) 58 (92.1)
 Charlson Comorbidity Index, mean (SD) 2.1 (1.8) 2.5 (2.0) 2.3 (1.9) 2.1 (1.8) 2.4 (2.0) 2.3 (1.9) 2.2 (1.7) 3.0 (1.7) 2.5 (1.7)
Comorbidities in admission notes, n (%)
 Hypertension 75 (51.7) 69 (50.4) 144 (50.5) 54 (50.9) 58 (50.0) 110 (49.6) 21 (50.0) 11 (52.4) 32 (50.8)
 Asthma or COPD 44 (29.7) 38 (27.7) 82 (28.8) 34 (32.1) 33 (28.5) 67 (30.2) 10 (23.8) 5 (23.8) 15 (23.8)
 Atrial fibrillation 37 (25.0) 42 (30.7) 79 (27.7) 25 (23.6) 36 (31.0) 61 (27.5) 12 (28.6) 6 (28.6) 18 (28.6)
 Diabetes 28 (18.9) 31 (22.6) 59 (20.7) 21 (19.8) 25 (21.6) 46 (20.7) 7 (16.7) 6 (28.6) 13 (20.6)
 Heart failure 24 (16.2) 21 (15.3) 45 (15.8) 14 (13.2) 17 (14.7) 31 (14.0) 10 (23.8) 4 (19.1) 14 (22.2)
 Renal failure 24 (16.2) 21 (15.3) 45 (15.8) 14 (13.2) 16 (13.8) 30 (13.5) 4 (9.5) 0 (0.0) 4 (6.4)
 Anxiety/depression 17 (11.5) 11 (8.0) 28 (9.8) 11 (10.4) 10 (8.6) 21 (9.5) 10 (23.8) 5 (23.8) 15 (23.8)
 Dementia 7 (4.7) 4 (2.9) 11 (3.9) 3 (2.8) 4 (3.5) 7 (3.2) 4 (9.5) 0 (0.0) 4 (6.4)
 Died during the study period, n (%) 14 (9.5) 12 (8.8) 26 (9.1) 7 (6.6) 10 (8.6) 17 (7.7) 7 (16.7) 2 (9.5) 9 (14.3)
Study ward, n (%)
 Ward 1 117 (79.1) 103 (75.2) 220 (77.2) 80 (75.5) 85 (73.3) 165 (74.3) 37 (88.1) 18 (85.7) 55 (87.3)
 Ward 2 31 (21.0) 34 (24.8) 65 (22.8) 26 (24.5) 31 (26.7) 57 (25.7) 5 (11.9) 3 (14.3) 8 (12.8)

aPercentages were rounded

COPD Chronic Obstructive Pulmonary Disease; SD standard deviation; CI confidence interval